ライフサイエンスコーパス: subclassified

1 hylogenomic approach, we have identified and subclassified a new family of carotenoid-binding protein

2 development and internal validation sets and subclassified according to height-adjusted TKV (HtTKV) r

3 Cases without SMN1 mutations are subclassified according to phenotype.

4 sected PDAC patients with follow-up data was subclassified according to predominant growth pattern, a

5 , the action tremors of the upper limbs were subclassified according to the predominant site and stat

6 Patients were subclassified according to the presence of donor coronar

7 s with acute pancreatitis, of which 107 were subclassified according to the revised Atlanta criteria

8 Patients were subclassified according to the Verhaak and Phillips clas

9 Tonic S neurones were subclassified, according to their post-stimulus response

10 ory data were collected on patients who were subclassified and serially revalidated based on publishe

11 These donors were subclassified as "active COVID-19" (aCOV) donors if they

12 This RiPP, subclassified as a sactipeptide, requires the host diges

13 Expressed genes were subclassified as able to express both mRNAs and proteins

14 NERD is subclassified as abnormal acid exposure (AAE) and normal

15 AR was subclassified as antibody (Ab)-treated AR or other manag

16 Lobar CMBs were subclassified as cortical or subcortical.

17 G:C-A:T transitions were also subclassified as CpG or non-CpG.

18 CP to a more advanced phase, which has been subclassified as either accelerated phase or blastic pha

19 These reactions are subclassified as either type I or type II depending on h

20 tologically aggressive component was further subclassified as frank LCL or as L&H-cell-rich, but not

21 The follicular component was subclassified as grade 3a (FL3a) or grade 3b (FL3b) acco

22 41%) were deemed TheraP-I; of those, 24 were subclassified as having discordant disease.

23 out a history of heart failure at enrolment, subclassified as heart failure with preserved ejection f

24 We estimated outcomes based on HT, subclassified as hemorrhagic infarction (HI) or parenchy

25 PAH is now further subclassified as idiopathic PAH, familial PAH, and assoc

26 ACHD diagnoses were subclassified as isolated aortic valve and noncomplex de

27 ed thickening (HAT) on the device, which was subclassified as low grade or high grade.

28 ligible (TheraP-I), the latter of which were subclassified as low PSMA or discordant.

29 receptors (EP(1)-EP(4)), that can be further subclassified as low-affinity (EP(1) and EP(2)) or high-

30 minimum threshold of lung involvement) were subclassified as mild (all interstitial abnormalities in

31 tive emphysema), panlobular, and paraseptal (subclassified as mild or substantial).

32 Lobulation, atrophy, and hypertrophy were subclassified as mild-moderate or severe.

33 linical disease severity (Atlanta criteria); subclassified as multiorgan dysfunction (MOF), pancreati

34 ic macular edema [DME]) or "any DR" (further subclassified as NPDR or PDR, without or with DME).

35 which was not significant when patients were subclassified as producers and non-producers of cytochro

36 nodule) and were otherwise classified as NS (subclassified as pure or heterogeneous).

37 0 mum in length and < 100 mum in height were subclassified as SIRE.

38 The 263 MIs were subclassified as spontaneous MI (n=78; 29.7%), secondary

39 Emphysema is classified as centrilobular (subclassified as trace, mild, moderate, confluent, and a

40 ustained tactile stimulation; the former are subclassified as Type 1 or 2 based on the regularity of

41 All cases were clinically subclassified at presentation as amnestic AD dementia ve

42 Poised enhancers can also be subclassified based on presence or absence of H3K27me3 a

43 ous group of neoplasms and are traditionally subclassified based on type and degree of differentiatio

44 cally, we found that active enhancers can be subclassified based on varying levels of H3K4me1, H3K27a

45 re stained with subtype-specific markers and subclassified by a pathologist.

46 d household income, with cirrhosis diagnoses subclassified by aetiology and presence of major adverse

47 Overall, 156 single units were isolated, subclassified by cell-type and tracked through the seizu

48 tudy confirms that most so-called MFH can be subclassified by defined criteria; it provides evidence

49 Incidence of colorectal carcinoma subclassified by F nucleatum status in tumor tissue, det

50 t-naive patients with achalasia, defined and subclassified by high-resolution esophageal pressure top

51 ssified as Hispanic or non-Hispanic and then subclassified by race forming six race-specific subgroup

52 Full-thickness macular hole is subclassified by size of the hole as determined by OCT a

53 Non-EoE EGIDs are further subclassified by the area of the GI tract that is involv

54 Vitreomacular traction can be subclassified by the diameter of vitreous attachment to

55 T2MI was further subclassified by the inciting event for supply/demand mi

56 This set of peptides was subclassified by their capacity to sensitize targets whe

57 Cell-line-defined super-enhancers can be subclassified by their somatic alteration status into so

58 ally unclassifiable by the LPD analyses were subclassified by this signature.

59 higher-order thinking questions were further subclassified by type (description of imaging findings,

60 eceipt vs nonreceipt of concomitant BRIs and subclassified by volume of disease (high volume or low v

61 ians who were blinded to the study treatment subclassified causes of death as cardiovascular (cardiac

62 amples by CD40 activation status and further subclassified CD40-activated CLL cells from healthy B ce

63 ing the frontal and temporal lobes, has been subclassified clinically into behavioral variant FTD; pr

64 We further subclassified genuine oligometastatic disease into repea

65 Forty-nine HCAs were subclassified into 14 inflammatory, 20 hepatocyte nuclea

66 xylase (GAD)-positive interneurons that were subclassified into at least four groups based on nAChR s

67 When further subclassified into botanical groups, the observed invers

68 mouse lungs are not homogeneous, but can be subclassified into capsaicin-sensitive and capsaicin-ins

69 The patients were subclassified into categories of body mass index (BMI) d

70 R0 margins were subclassified into clear (>1 mm) or close (<=1 mm).

71 Primary chronic daily headache can be subclassified into disorders of short duration (<4 h/att

72 a single disease entity, but one that can be subclassified into distinct clinical prognostic stages,

73 ents with esophageal hypersensitivity may be subclassified into distinct phenotypic subclasses based

74 als who developed a "unique" CRC, which were subclassified into early-onset CRC (EOCRC) and late-onse

75 Vascular malformation is subclassified into fast-flow, including arteriovenous ma

76 published research articles was recorded and subclassified into first-author publications in any fiel

77 s of stay were compared with body mass index subclassified into five groups: underweight, normal weig

78 tive and EpCAM-negative HCC could be further subclassified into four groups with prognostic implicati

79 ffuse large B-cell lymphomas (DLBCLs) can be subclassified into germinal center B-cell (GCB)-like and

80 a serovars, and some of these can be further subclassified into groups of strains that differ profoun

81 iMCD can be further subclassified into iMCD-thrombocytopenia, ascites, retic

82 complications associated with the procedure (subclassified into life-threatening or non-life-threaten

83 , based on these distinctions, ITG should be subclassified into monoclonal and polyclonal variants.

84 a that develops in adults, is pathologically subclassified into monophasic spindle synovial sarcoma a

85 malignant brain tumor in children and can be subclassified into multiple entities.

86 pathological criteria, patients were further subclassified into nine AD, eight DLB, ten PD and nine w

87 Each subject was subclassified into one of five groups: obstructive physi

88 Mortality was subclassified into overall mortality (during 10 years of

89 ty and experience grading system for MIPD is subclassified into patient-related risk factors and prov

90 a suggest that most patients with MFH can be subclassified into specific STS types, but the clinical

91 Assemblage A has been subclassified into subtypes A-I to A-IV: A-I has been re

92 RC), and patients with multiple primary CRCs subclassified into synchronous CRC (SCRC) and metachrono

93 Group I patients were subclassified into those undergoing MVR with chordal pre

94 variants of GCN2 that we identified could be subclassified into three groups: misfolded, kinase-dead,

95 Patients with PAD were subclassified into three groups: type I, II, and II, wit

96 Our data indicate that BC can be subclassified into three subtypes, on the basis of their

97 Regarding MM, we subclassified ISS stages into clusters based on shared f

98 Recent collaborative efforts have subclassified malignant glioblastomas into 4 clinical re

99 ween cultured neurons, and chromatin domains subclassified on the basis of transcriptional activity.

100 es mostly confirmed the cytogenetic data and subclassified patients according to 14q32 translocations

101 We have subclassified the molecular substrates by system, focusi

102 trahepatic from extrahepatic tumors and have subclassified this latter group into proximal, middle, a

103 Participants' knowledge was further subclassified using Bloom's original cutoff points into

104 Cases were subclassified using CD10, bcl-6, and MUM1 expression, an

105 Patients were subclassified (using the Kiel classification) as having